| Drug Name: | Sultiame (61-56-3) |
|---|---|
| PubChem ID: | 5356 |
| SMILES: | C1CCS(=O)(=O)N(C1)C2=CC=C(C=C2)S(=O)(=O)N |
| InchiKey: | HMHVCUVYZFYAJI-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 290.366 |
| LogP | : | 0.264 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 4 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 97.54 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Phenytoin (57-41-0) | Phenytoin Toxicity | Synergistic | sultiame interferes with the metabolism of the phenytoin by the liver, leading to its accumulation in the body. | Drug--interaction between sulthiame (Ospolot (R)) and phenytoin in the treatment of epilepsy |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|